MGC Pharma

DECEMBER 12, 2017

A word from Elad Segev, Manager of Breeding and Cultivation at MGC Pharmaceuticals. A Cannabis plant is made up of 400 different chemicals that have physical and psychoactive effects when consumed together. The addition or removal of these substances from a plant can cause very different results, which can potentially lower the efficacy of the plant.

Epilepsy 100

Epilepsy Pharmaceutical Cannabinoids THC 100

Peninsula Alternative Health

DECEMBER 14, 2017

Americans for Safe Access (ASA), a medical patient advocacy group, has an annual report on the proficiency of states’ medical cannabis programs, assigning each a letter grade. Criteria includes patient rights and civil protection from discrimination (including protection against arrest and driving under the influence), ease of access, reasonable fees and qualifying conditions, fair purchase and possession limits, and consumer safety and provider requirements.

Safety 63

Safety Access Dispensary Programs 63

MedicalJane

DECEMBER 13, 2017

Introduced in July 2014, New York’s medical marijuana program has been a work in progress from the get-go. The state recently announced an expansion to its program that is beginning to open the door to improved patient access. These changes included adding chronic pain and PTSD to its list of qualifying medical conditions. Chronic pain, on its own, is already responsible for more than 7,500 new patients joining New York’s MMJ program.

Programs 49

Programs Patients Chronic Pain Marijuana 49

Peninsula Alternative Health

DECEMBER 14, 2017

Americans for Safe Access (ASA), a medical patient advocacy group, has an annual report on the proficiency of states’ medical cannabis programs, assigning each a letter grade. Criteria includes patient rights and civil protection from discrimination (including protection against arrest and driving under the influence), ease of access, reasonable fees and qualifying conditions, fair purchase and possession limits, and consumer safety and provider requirements.

Safety 40

Safety Dispensary Access Patients 40

Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken

The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.

Cannabis